|
IPO9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.699600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.701560E-01 |
| Normal-vs-Stage2 |
7.464000E-01 |
| Normal-vs-Stage3 |
2.690200E-01 |
| Normal-vs-Stage4 |
1.681790E-01 |
| Stage1-vs-Stage2 |
5.218600E-01 |
| Stage1-vs-Stage3 |
8.042600E-03 |
| Stage1-vs-Stage4 |
5.982500E-03 |
| Stage2-vs-Stage3 |
2.384800E-01 |
| Stage2-vs-Stage4 |
1.520040E-01 |
| Stage3-vs-Stage4 |
7.337000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.135400E-01 |
| Normal-vs-AfricanAmerican |
5.000800E-01 |
| Normal-vs-Asian |
2.823800E-01 |
| Caucasian-vs-AfricanAmerican |
3.517200E-01 |
| Caucasian-vs-Asian |
4.124800E-01 |
| AfricanAmerican-vs-Asian |
2.679000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.187200E-01 |
| Normal-vs-Female |
3.110200E-01 |
| Male-vs-Female |
9.191500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.921600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.045200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.502000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.884800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.532000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.747400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.171400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.340600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.965400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.726400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.605300E-04 |
| Normal-vs-Grade 2 |
2.164600E-01 |
| Normal-vs-Grade 3 |
4.197600E-01 |
| Normal-vs-Grade 4 |
1.903830E-01 |
| Grade 1-vs-Grade 2 |
1.094380E-02 |
| Grade 1-vs-Grade 3 |
6.761800E-04 |
| Grade 1-vs-Grade 4 |
6.566200E-04 |
| Grade 2-vs-Grade 3 |
1.458300E-02 |
| Grade 2-vs-Grade 4 |
1.161570E-02 |
| Grade 3-vs-Grade 4 |
4.354000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.837700E-03 |
| Normal-vs-ccB subtype |
1.974960E-01 |
| ccA subtype-vs-ccB subtype |
2.9495000000157E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.702400E-01 |
| Normal-vs-N1 |
4.828800E-01 |
| N0-vs-N1 |
4.723800E-01 |
|
|
